Peizhi Luo
Vorstandsvorsitzender bei ADAGENE INC.
Vermögen: 22 Mio $ am 30.04.2024
Profil
Pei Zhi Luo is the Chairman & Chief Executive Officer of Adagene, Inc., a company he founded in 2011.
He is also the President, Director & Chief Technology Officer of Abmaxis, Inc., a company he founded in 2000.
Dr. Luo previously worked as a Director-Biologics Technology at Merck & Co., Inc. and as a Scientist at Xencor, Inc. He received his undergraduate degree from Peking University in 1986, his doctorate degree from The University of Chicago in 1995, and his graduate degree from the Chinese Academy of Sciences in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADAGENE, INC.
21,37% | 29.01.2024 | 11 622 853 ( 21,37% ) | 22 Mio $ | 30.04.2024 |
Aktive Positionen von Peizhi Luo
| Unternehmen | Position | Beginn |
|---|---|---|
| ADAGENE INC. | Vorstandsvorsitzender | 01.11.2011 |
Ehemalige bekannte Positionen von Peizhi Luo
| Unternehmen | Position | Ende |
|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Gründer | 06.11.2008 |
| XENCOR, INC. | Corporate Officer/Principal | 01.08.2000 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Ausbildung von Peizhi Luo
| The University of Chicago | Doctorate Degree |
| Peking University | Undergraduate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
